ERCC1 and non-small cell lung carcinoma: Our in vitro functional assays put forward that miR‐15a acted as an enhancer of the sensitivity of NSCLC cells to cisplatin, which might contribute to elevating the benefits of platinum‐based chemotherapy in patients carrying rs3212986 C allele via altering the post‐transcriptional regulation of ERCC1.